A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia.

Osborne Ashleigh L., Solowij Nadia, Weston-Green Katrina
Neuroscience & Biobehavioral Reviews, 2017

Abstract

Background and objectives

Cognitive impairment is a core symptom domain of schizophrenia, neurological disorders and substance abuse. It is characterised by deficits in learning, memory, attention and executive functioning and can severely impact daily living. Antipsychotic drugs prescribed to treat schizophrenia provide limited cognitive benefits and novel therapeutic targets are required. Cannabidiol (CBD), a component of the cannabis plant, has anti-inflammatory and antipsychotic-like properties; however, its ability to improve cognitive impairment has not been thoroughly explored. The aim of this systematic review was to evaluate preclinical and clinical literature on the effects of CBD in cognitive domains relevant to schizophrenia.

Methods

A systematic literature search was performed across numerous electronic databases for English language articles (January 1990-March 2016), with 27 articles (18 preclinical and 9 clinical studies) included in the present review.

Results

CBD improves cognition in multiple preclinical models of cognitive impairment, including models of neuropsychiatric (schizophrenia), neurodegenerative (Alzheimer's disease), neuro-inflammatory (meningitis, sepsis and cerebral malaria) and neurological disorders (hepatic encephalopathy and brain ischemia). To date, there is one clinical investigation into the effects of CBD on cognition in schizophrenia patients, with negative results for the Stroop test. CBD attenuates Δ9-THC-induced cognitive deficits.

Conclusions

The efficacy of CBD to improve cognition in schizophrenia cannot be elucidated due to lack of clinical evidence; however, given the ability of CBD to restore cognition in multiple studies of impairment, further investigation into its efficacy in schizophrenia is warranted. Potential mechanisms underlying the efficacy of CBD to improve cognition are discussed.

Keywords

Alzheimer’s disease; Antipsychotic drugs; Brain ischemia; Cannabidiol; Cannabis; Cerebral malaria; Cognition; Cognitive impairment; Cognitive testing; Hepatic encephalopathy; Meningitis; Neuro-inflammation; Neurodegeneration; Neuropsychiatric; Schizophrenia; Sepsis; Δ9-Tetrahydrocannabinol.

Copyright © 2016 Elsevier Ltd. All rights reserved.

PMID:27884751
DOI:10.1016/j.neubiorev.2016.11.012
Category:Brain / Mental Clarity

The best supplements with Cannabidiol in Brain / Mental Clarity category:

Articles similar to "A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia."

  • The significance of Cannabidiol for Brain / Mental Clarity: Antidepressant-like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa. (Anxiety and depression are pathologies that affect human beings in many aspects of life, including social life, productivity and health...)
  • The impact of Cannabidiol on Brain / Mental Clarity: Evidences for the Anti-panic Actions of Cannabidiol. ( Panic disorder (PD) is a disabling psychiatry condition that affects approximately 5% of the worldwide population...)
  • The significance of Cannabidiol for Brain / Mental Clarity: Cannabidiol as a Potential Treatment for Anxiety Disorders. (Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum drug that in recent years has drawn increasing interest as a treatment for a range of neuropsychiatric disorders...)
  • The role of Cannabidiol in Brain / Mental Clarity: Cannabidiol, a Cannabis Sativa Constituent, as an Anxiolytic Drug. (Objectives: To review and describe studies of the non-psychotomimetic constituent of Cannabis sativa, cannabidiol (CBD), as an anxiolytic drug and discuss its possible mechanisms of action... Future clinical trials involving patients with different anxiety disorders are warranted, especially of panic disorder, obsessive-compulsive disorder, social anxiety disorder, and post-traumatic stress disorders. The adequate therapeutic window of CBD and the precise mechanisms involved in its anxiolytic action remain to be determined.)
  • The impact of Cannabidiol on Brain / Mental Clarity: Cannabidiol, a Cannabis Sativa Constituent, as an Antipsychotic Drug. (A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers... Future clinical trials involving patients with different anxiety disorders are warranted, especially of panic disorder, obsessive-compulsive disorder, social anxiety disorder, and post-traumatic stress disorders. The adequate therapeutic window of CBD and the precise mechanisms involved in its anxiolytic action remain to be determined.)
  • The significance of Cannabidiol for Brain / Mental Clarity: Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. (The broad presence of CB1 receptors in the basal ganglia, mainly in GABA- or glutamate-containing neurons, as well as the presence of TRPV1 receptors in dopaminergic neurons and the identification of CB2 receptors in some neuronal subpopulations within the basal ganglia, explain the powerful motor effects exerted by those cannabinoids that can activate/block these receptors... Collectively, these results suggest that CBD may influence motor activity, in particular vertical activity, and that this effect seems to be dependent on its ability to target the 5-HT1A receptor, a mechanism of action that has been proposed to account for its anti-emetic, anxiolytic and antidepressant effects. )
  • The role of Cannabidiol in Brain / Mental Clarity: Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. (Epilepsy is the most common neurological disorder, with over 50 million people worldwide affected... Collectively, these results suggest that CBD may influence motor activity, in particular vertical activity, and that this effect seems to be dependent on its ability to target the 5-HT1A receptor, a mechanism of action that has been proposed to account for its anti-emetic, anxiolytic and antidepressant effects. )

Previous article

Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects.

Next article

Systematic Exploration of Astragalus Membranaceus and Panax Ginseng as Immune Regulators: Insights From the Comparative Biological and Computational Analysis.